Envision Pharma Group

In our webinar, "Medical, reimagined: How technology-driven insights can help us rethink strategy and execution," we engaged with participants to explore their perspectives on the technology advancements in healthcare. We delved into the challenges they encounter while integrating new technologies into medical affairs to create a more efficient, effective, and inspiring scientific future for pharma.   Discover our report and contact us for the webinar recording 👉 [email protected].

Emerging pharma companies face immense challenges in navigating the complex path to commercialization. 🧬 In our latest eBook, we take a deep dive into a success story that fueled the incredible growth of an emerging pharma company. Through a strategic partnership, we helped our client overcome key obstacles, clearing the path for their commercial success. The result? A remarkable transformation into a thriving organization valued at $6.7 billion. Download our eBook to learn how strategic transformation can position your biotech for sustained success. 👇 https://lnkd.in/esGyK-vF #HealthcareInnovation #LifeSciences #GrowthStrategy

What an amazing accomplishment for 90TEN! These accolades recognize the incredible work 90TEN has done, particularly in partnership with Novartis on the COSMOS program. Their efforts are equipping HCPs with essential tools to enhance MS services, showcasing the exceptional impact of their initiatives. Congratulations to the entire 90TEN team. Your achievements elevate Envision’s capabilities, allowing us to deliver even greater value to our clients. #CommuniqueAwards #ProfessionalEducation #HealthcareExcellence #EnvisionPharma #90TEN #Novartis #COSMOS #LifeSciences

In our recent webinar, “Medical, reimagined: How technology-driven insights can help us rethink strategy and execution,” we aimed to go beyond the theory, offering a concrete vision of how AI can redefine every facet of medical work to be more efficient, effective, and inspiring for the scientific future of pharma. Hear from Jim Streeter, President of Technology, CTO at Envision Pharma Group, about how AI can be a real game changer for the future of life sciences. To watch the full recording, reach us at 👉 [email protected].

Two Labs Kyle Felmet and Riparian LLC’s Jennifer Lospinoso co-authored an insightful blog that highlights key strategies and innovative methods shaping the future of cell and gene therapy. Discover how early planning and new approaches ensure these cutting-edge therapies reach patients quickly and effectively.

As #Pride Month 2024 draws to a close, Envision Pharma Group is proud to support the power of pride and allyship that has been displayed by our people across the globe. While raising money for local LGBTQI charities, we have enjoyed cake bakes, a Pride playlist, origami making, Pride picnics, and LGBTQI -themed quizzes! This month has also seen us partner with the Proud Science Alliance, joining them in their aim to further LGBTQI inclusion in the healthcare and life sciences sector globally.

Last week, two of our Envision Pharma Group teammates from 90TEN, Robert Goodwin and Sarah Avent attended Patient Centricity & Engagement Conference in Amsterdam, Netherlands- and left feeling optimistic about the industry's direction! With a growing number of pharma companies learning from one another, collaborating and endorsing each other’s work, they anticipate a further culture shift forward for patient involvement in medicine development. We can't wait to see how Sarah and Rob will bring to life the inspiring new ideas shared on demonstrating the internal and external value of patient community partnerships!  #patientengagement

In our recent webinar “Medical, reimagined: How technology-driven insights can help us rethink strategy and execution,” we envisioned the future of medical affairs, focusing on the transformative roles of AI and tech solutions for life sciences. Here are the key insights: Reevaluating medical affairs: We explored evolving responsibilities, including data collection, evidence generation, key opinion leader engagement, and authentic healthcare professional (HCP) interactions, envisioning a data-based approach for the future. Unlocking data: The need to gather data from both private and public sources is crucial for enabling more personalized and impactful interactions with healthcare professionals. AI plays a vital role in generating these valuable insights. AI-powered insights: Leveraging large language models and multimodal models, AI's dynamic analysis of data from many sources can significantly shorten the cycle from evidence to practice, offering deeper, actionable insights for patient care. Revolutionizing information delivery: AI tailors medical information to HCPs' needs, improving accessibility and decision-making, thus elevating patient care. When we don’t even notice AI working in the background for us will be the time that it’s revolutionary. Our session transcended theory, presenting a concrete vision of AI's potential to redefine medical affairs – making it more efficient, effective, and inspiring the future of pharma. The time to action is NOW. To watch the full recording, reach us at 👉 [email protected]

"Patient-centric" isn’t just a buzzword; it’s fundamental to the evolution of healthcare. By incorporating patient perspectives early in the development process, we can streamline drug development and commercialization, significantly improving health outcomes. Join us in this patient-centric reformation. Elevating the voices of patient advocacy groups and incorporating real-world patient data isn't just about meeting regulatory guidelines – it’s about creating therapies that truly meet patient needs and improve lives. Our latest blog by Dominic Marasco, Envision’s Executive President and Chief Commercial Officer, and Jessica Krauser, Envision's Marketing Advisor and Founder of 5kforJK, talks about how we’re leading the way in harnessing patient perspectives for a better future in drug development and commercialization. Read it here: https://lnkd.in/e5cg9KPi #MedicalAffairs #PatientEngagement #HealthcareTransformation #EnvisionPharmaGroup

Our new, thought-provoking webinar is tomorrow! There is still time to register and reimagine medical affairs. “Medical, reimagined: How technology-driven insights can help us rethink strategy and execution.” Participate with our speakers at 10.00 (EST) | 15.00 (GMT) | 16.00 (CEST) on June 25, by registering at👇 https://lnkd.in/dKjvQS2K